Form 4: Marimed Inc. CFO Mario Pinho Acquires 214,286 Restricted Stock Units

Chief Financial Officer of Marimed Inc., Mario Pinho, reports the acquisition of 214,286 Restricted Stock Units (RSUs) that will vest quarterly starting March 31, 2025.

Summary

• Mario Pinho, the Chief Financial Officer of Marimed Inc., filed a Form 4 to report changes in beneficial ownership.
• On February 18, 2025, Mr. Pinho acquired 214,286 Restricted Stock Units (RSUs).
• These RSUs convert to common stock on a one-for-one basis.
• The RSUs will vest in quarterly installments, with one-fourth vesting on March 31, 2025, and subsequent one-fourth portions vesting every three months thereafter for the following nine months.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock unit acquisition, with neutral sentiment.

Future Outlook

The document outlines the vesting schedule for the acquired RSUs, indicating future equity ownership changes for the reporting person.

Industry Context

This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies. It provides transparency regarding the alignment of management's interests with those of shareholders.

Stakeholder Impact

• The acquisition of RSUs by the CFO aligns his interests with those of the shareholders, potentially incentivizing him to improve company performance.
• The vesting schedule ensures a long-term commitment from the CFO.

Next Steps

• The RSUs will continue to vest quarterly according to the schedule outlined in the document.
• Future Form 4 filings may be required if there are further transactions involving Marimed Inc. securities by Mr. Pinho.

Key Dates